PMS19 - A BUDGET IMPACT ANALYSIS OF INTRODUCING A FORCED TREATMENT PATHWAY USING THE LOWEST PRICED ANTI-TUMOR NECROSIS FACTOR AGENT FOR RHEUMATOID ARTHRITIS AND ANKYLOSING SPONDYLITIS IN THE PHILIPPINES

Oct 1, 2018, 00:00
10.1016/j.jval.2018.09.1733
https://www.valueinhealthjournal.com/article/S1098-3015(18)35035-6/fulltext
Title : PMS19 - A BUDGET IMPACT ANALYSIS OF INTRODUCING A FORCED TREATMENT PATHWAY USING THE LOWEST PRICED ANTI-TUMOR NECROSIS FACTOR AGENT FOR RHEUMATOID ARTHRITIS AND ANKYLOSING SPONDYLITIS IN THE PHILIPPINES
Citation : https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(18)35035-6&doi=10.1016/j.jval.2018.09.1733
First page :
Section Title :
Open access? : No
Section Order : 1097
Categories :
Tags :
Regions :
ViH Article Tags :